Richard Aldrich - Net Worth and Insider Trading
Richard Aldrich Net Worth
The estimated net worth of Richard Aldrich is at least $23 Million dollars as of 2024-04-23. Richard Aldrich is the Director of KalVista Pharmaceuticals Inc and owns about 934,484 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $11 Million. Richard Aldrich is the Director of Verastem Inc and owns about 707,436 shares of Verastem Inc (VSTM) stock worth over $7 Million. Richard Aldrich is also the Director of Concert Pharmaceuticals Inc and owns about 596,977 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $5 Million. Besides these, Richard Aldrich also holds Millendo Therapeutics Inc (MLND) , PTC Therapeutics Inc (PTCT) . Details can be seen in Richard Aldrich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Aldrich has not made any transactions after 2022-06-06 and currently still holds the listed stock(s).
Transaction Summary of Richard Aldrich
Richard Aldrich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Aldrich owns 11 companies in total, including Concert Pharmaceuticals Inc (CNCE) , Millendo Therapeutics Inc (MLND) , and KalVista Pharmaceuticals Inc (KALV) among others .
Click here to see the complete history of Richard Aldrich’s form 4 insider trades.
Insider Ownership Summary of Richard Aldrich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNCE | Concert Pharmaceuticals Inc | 2022-06-06 | director |
| MLND | Millendo Therapeutics Inc | 2018-12-07 | director |
| KALV | KalVista Pharmaceuticals Inc | 2017-10-12 | director |
| PTCT | PTC Therapeutics Inc | 2015-06-08 | director |
| VSTM | Verastem Inc | 2014-05-20 | director |
| BSTC | BioSpecifics Technologies Corp | 2008-11-17 | 10 percent owner |
| ARDMQ | Aradigm Corp | 2008-10-29 | 10 percent owner |
| SQNM | Sequenom Inc | 2008-07-10 | 10 percent owner |
| CRIS | Curis Inc | 2007-08-08 | 10 percent owner |
| EPRSQ | EPIRUS Biopharmaceuticals Inc | 2006-09-28 | director |
| TPST | Tempest Therapeutics Inc | 2013-06-07 | director & 10 percent owner |
Richard Aldrich Latest Holdings Summary
Richard Aldrich currently owns a total of 5 stocks. Among these stocks, Richard Aldrich owns 934,484 shares of KalVista Pharmaceuticals Inc (KALV) as of October 12, 2017, with a value of $11 Million and a weighting of 47.39%. Richard Aldrich owns 707,436 shares of Verastem Inc (VSTM) as of May 20, 2014, with a value of $7 Million and a weighting of 30.42%. Richard Aldrich also owns 596,977 shares of Concert Pharmaceuticals Inc (CNCE) as of June 6, 2022, with a value of $5 Million and a weighting of 22.15%. The other 2 stocks Millendo Therapeutics Inc (MLND) , PTC Therapeutics Inc (PTCT) have a combined weighting of 0.04% among all his current holdings.
Latest Holdings of Richard Aldrich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2017-10-12 | 934,484 | 11.44 | 10,690,497 |
| VSTM | Verastem Inc | 2014-05-20 | 707,436 | 9.70 | 6,862,129 |
| CNCE | Concert Pharmaceuticals Inc | 2022-06-06 | 596,977 | 8.37 | 4,996,697 |
| MLND | Millendo Therapeutics Inc | 2016-06-01 | 8,729 | 1.06 | 9,253 |
| PTCT | PTC Therapeutics Inc | 2015-06-08 | 0 | 25.97 | 0 |
Holding Weightings of Richard Aldrich
Richard Aldrich Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Aldrich has made a total of 0 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years. The most-recent trade in KalVista Pharmaceuticals Inc is the acquisition of 565,065 shares on October 12, 2017, which cost Richard Aldrich around $5 Million.
According to the SEC Form 4 filings, Richard Aldrich has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 1,000 shares on May 20, 2014, which cost Richard Aldrich around $8,370.
According to the SEC Form 4 filings, Richard Aldrich has made a total of 1 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Concert Pharmaceuticals Inc is the acquisition of 210,526 shares on June 6, 2022, which cost Richard Aldrich around $999,998.
More details on Richard Aldrich's insider transactions can be found in the Insider Trading History of Richard Aldrich table.Insider Trading History of Richard Aldrich
- 1
Richard Aldrich Trading Performance
GuruFocus tracks the stock performance after each of Richard Aldrich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Aldrich is 6.58%. GuruFocus also compares Richard Aldrich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Aldrich within 3 months outperforms 20 times out of 48 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Aldrich's insider trading performs compared to the benchmark.
Performance of Richard Aldrich
Average Return
31.98%
Outperforming Transactions
30%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.46 | 6.58 | 47.77 | 31.98 | -36.27 | -47.3 |
| Relative Return to S&P 500(%) | -1.75 | 2.59 | 40.9 | 17.81 | -45.87 | -56.5 |
Richard Aldrich Ownership Network
Ownership Network List of Richard Aldrich
Ownership Network Relation of Richard Aldrich
Richard Aldrich Owned Company Details
What does Concert Pharmaceuticals Inc do?
Who are the key executives at Concert Pharmaceuticals Inc?
Richard Aldrich is the director of Concert Pharmaceuticals Inc. Other key executives at Concert Pharmaceuticals Inc include Chief Development Officer James V Cassella , CFO & PFO Marc A. Becker , and Chief Operating Officer Nancy Stuart .
Concert Pharmaceuticals Inc (CNCE) Insider Trades Summary
Over the past 18 months, Richard Aldrich made no insider transaction in Concert Pharmaceuticals Inc (CNCE). Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 12,999 shares made by James V Cassella , and a net sale of 11,386 shares made by Jeffrey A Munsie .
In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.
Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Concert Pharmaceuticals Inc Insider Transactions
Richard Aldrich Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Aldrich. You might contact Richard Aldrich via mailing address: 1365 Main Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
